Alterola Biotech, Inc.

ABTI · OTC
Analyze with AI
3/31/2023
3/31/2022
9/30/2020
9/30/2019
Operating Activities
Net Income-$1,742-$6,471-$251-$259
Dep. & Amort.$137$0$0$0
Deferred Tax-$190$0$0$0
Stock-Based Comp.$803$0$130$126
Change in WC-$35$756$121$133
Other Non-Cash-$12$5,759$0$0
Operating Cash Flow-$1,040$44$0$0
Investing Activities
PP&E Inv.-$140$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$140$0$0$0
Financing Activities
Debt Repay.
Stock Issued$50$369$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1,162-$378$0$0
Financing Cash Flow$1,212-$10$0$0
Forex Effect-$88$29$0$0
Net Chg. in Cash-$55$63$0$0
Supplemental Information
Beg. Cash$64$1$0$0
End Cash$9$64$0$0
Free Cash Flow-$1,180$44$0$0